Approval · Notice of Compliance 18170 · 2016
ADCETRIS: Notice of Compliance 18170
Issued June 10, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18170
- Date
- June 10, 2016
- Company
- Seattle Genetics Inc
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Fulfillment of commitments C,E, O and P of the letter of undertaking
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADCETRIS | Not yet assigned | — |
Medicinal ingredients
- BRENTUXIMAB VEDOTIN 50 MG per VIAL